Physician profile
Swathi Malepati
NPI 1184075020
$17,437.81
in general payments reported to CMS, 2019-2025
20 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,772 · 2022: $8,844 · 2023: $2,093 · 2024: $402 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137 · Travel and Lodging: $1,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.82 |
| Travel and Lodging | $1,685.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,726.70 | 2021-2024 | Da Vinci Surgical System |
| Axonics, INC. | $2,811.77 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $1,090.08 | 2025 | General - Therapies, Axonics, Advantage System |
| Coloplast Corp | $386.22 | 2023 | Altis |
| Baxter Healthcare | $341.52 | 2021-2025 | Tisseel |
| Abbvie INC. | $223.06 | 2021-2023 | |
| Hologic Sales and Service, LLC | $168.06 | 2022-2023 | Thinprep 2000 Processor, Aptima |
| Coopersurgical, INC. | $124.50 | 2025 | Ally II Ups |
| Organon LLC | $103.61 | 2022-2023 | Nexplanon |
| Myovant Sciences INC. | $99.83 | 2022 | |
| Pfizer INC. | $92.24 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $62.88 | 2023-2024 | Myfembree |
| Exeltis, USA INC. | $60.51 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.35 | 2021-2022 | |
| Daiichi Sankyo INC. | $24.98 | 2023 | Injectafer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $19.59 | 2022 | |
| Astellas Pharma US INC | $19.19 | 2023 | Veozah |
| Mayne Pharma Commercial LLC | $16.94 | 2021 | |
| Shield Therapeutics INC | $14.62 | 2023 | Accrufer |
| Alydia Health | $6.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swathi Malepati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.